US Stock MarketDetailed Quotes

SER Serina Therapeutics

Watchlist
  • 6.000
  • +0.466+8.41%
Close Dec 20 16:00 ET
  • 5.990
  • -0.010-0.17%
Post 20:01 ET
56.35MMarket Cap-100.00P/E (TTM)

About Serina Therapeutics Company

Serina Therapeutics, Inc. operates as a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley on March 26, 2024 and is headquartered in Huntsville, AL.

Company Profile

SymbolSER
Company NameSerina Therapeutics
Listing DateNov 29, 2018
Founded2024
CEOMr. Steven Ledger
MarketAMEX
Fiscal Year Ends12-31
Address601 Genome Way,Suite 2001
CityHuntsville
ProvinceAlabama
CountryUnited States of America
Zip Code35806
Phone1-256-327-9630
Websitehttp://serinatherapeutics.com/

Company Executives

  • Name
  • Position
  • Salary
  • Steven Ledger
  • Director and Chief Executive Officer
  • 237.50K
  • Gregory S. Curhan
  • Chief Financial Officer
  • --
  • Dr. Randall W. Moreadith,M.D.,PhD
  • Chief Development Officer
  • 433.88K
  • Dr. Srini Tenjarla, PhD
  • Senior Vice President, CMC and Formulation
  • --
  • Dr. Simba Gill, PhD
  • Chairman of the Board
  • --
  • Dr. Balkrishan Gill, PhD
  • Executive Chairman of the Board
  • --
  • Remy Gross
  • Independent Director
  • --
  • Steven M. Mintz
  • Independent Director
  • --
  • J. Milton Harris, PhD
  • Independent Director
  • --
  • Dr. Richard Marshall, M.D.
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data